Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7041292 Treating prostate cancer with anti-ErbB2 antibodies

Patent 7041292 was granted and assigned to Genentech on May, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

70412920

Patent Inventor Names

Mark X. Sliwkowski0

Date of Patent

May 9, 2006

Patent Application Number

096028000

Date Filed

June 23, 2000

Patent Citations Received

‌

US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof

‌

US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer

‌

US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer

Patent Primary Examiner

‌

Jeffrey Siew

Patent abstract

The present application discloses treatment of prostate cancer with anti-ErbB2 antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7041292 Treating prostate cancer with anti-ErbB2 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API